Orthocell Limited (ASX: OCC)
Australia
· Delayed Price · Currency is AUD
1.240
-0.010 (-0.80%)
Dec 20, 2024, 4:10 PM AEST
Orthocell Revenue
In the fiscal year ending June 30, 2024, Orthocell had annual revenue of 5.32M AUD with 25.27% growth. Orthocell had revenue of 3.91M in the half year ending June 30, 2024, with 409.36% growth.
Revenue
5.32M
Revenue Growth
+25.27%
P/S Ratio
47.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
296.71M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 5.32M | 1.07M | 25.27% |
Jun 30, 2023 | 4.24M | 2.71M | 177.01% |
Jun 30, 2022 | 1.53M | 513.76K | 50.47% |
Jun 30, 2021 | 1.02M | 298.44K | 41.48% |
Jun 30, 2020 | 719.52K | -226.13K | -23.91% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
ResMed Inc. | 6.93B |
Pro Medicus Limited | 161.50M |
Fisher & Paykel Healthcare Corporation Limited | 1.74B |
Cochlear Limited | 2.24B |
Sonic Healthcare Limited | 8.97B |
Telix Pharmaceuticals Limited | 645.68M |
Ramsay Health Care Limited | 16.66B |
Orthocell News
- 18 days ago - Perth’s billionaire set is piling into this little-known medtech - The Australian Financial Review